News & Events

Janes Capital Partners co-advises TDK Hutchinson Technology on the divestiture of its medical business to Resonetics, a portfolio company of GTCR

tdk-resonetics-gtcrDesigner and manufacturer of miniature electro-explosive components and subsystems supporting mission, flight, and life-critical applications to the aerospace and defense end-markets.